Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

London TMAU meeting with Prof Liz Shephard
19th Oct 11am - 1pm
St Mary's Hospital
Praed St, Paddington
London W2 1NY
click to read more
more details : karen.james@meboresearch.org

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Thursday, June 21, 2012

Conference Agenda for 3rd Annual MEBO Miami Beach Meetup 2012

I would like to thank everyone who has given donations to support the MEBO Research Alveolar Breath exploratory study to cover the cost of the room in which the tests will be administered for this study. Six (6) persons have purchased their tests for this event, and anyone interested can purchase it up to the last minute. The sample collection session will be held this Saturday, June 23rd, at the Dorchester South Beach Hotel after the Conference part of the Miami Beach Meetup. All donations, large and small, are very much appreciated and welcome at this time for this event.

MEBO Research


It is our goal to attempt to set up 2 conference calls throughout the whole of the conference, one using the local US conference phone line utilized for the bi-weekly calls, and the other a Skype Voice call. I cannot guarantee that the Skype call will be possible, but if you open an account to make domestic and international Skype calls in advance, you can purchase credits and take advantage of their very low long distance rates (usually cents per minute), and you can call the US conference phone line and listen in. More details and instructions will be posted in this blog tomorrow, the day before the conference.

USA : (712) 432 1620
access code : 391629#
NON USA : add 001 prefix


CONFERENCE AGENDA


The following is the agenda of the Conference to be held this Saturday, June 23rd at 12:00 noon and will last approximately 4 hours. The following days and weeks after the meetup, each presentation will be posted in this blog for everyone to see.

  1. PowerPoint Presentation by
    Elizabeth Shephard, PhD
    Professor of Molecular Biology
    Vice Dean Education, Biosciences
    Institute of Structural and Molecular Biology
    Division of Biosciences
    Darwin Building, UCL Genetics Institute
    University College London
    MEBO Research Scientific Advisor
    Member of the MEBO Institutional Review Board
    • Drug metabolism: If you have a mutation in a drug metabolizing enzyme that is needed to clear a particular drug, then there is very little detoxification and change in the drug, and the plasma concentration remains high. When taking the next dose, the same happens, thus the plasma concentration will increase over time without decreasing between each dose. This is potential for adverse effects, “adverse drug effects,” and in worst-case scenario, having too much drug, overdosing, and even death.
    • PHARMACOGENETICS (A field of genetics)--> PERSONALIZED MEDICINE:
      Pharmacogentics: The study of how our genes influence the way we handle a drug. Personalized medicine is, if we understand a person’s genetics, can we tailor their drug treatment to get them the best response to their particular drugs.

      Dr. Shephard gives an extensive list in her PowerPoint presentation of modern day medications that significantly challenge some metabolic pathways.
  2. PowerPoint Presentation by
    Dr. Colin Harvey-Woodworth, BDS
    UK MEBO Research Scientific Director
    Member of the MEBO Institutional Review Board
  3. Dimethylsufidemia: its significance in extra-oral blood borne halitosis:
    • Dimethylsulfide (DMS) appears to be a substrate of both CYP and FMO; renal and pulmonary excretion; DMS also demonstrated in cow milk after the cow’s dietary loading with either DMS or methionine
      1. DMS is a component of the odor of feces and flatus, along with H2S and methyl mercaptan
        (the same 3 VSC implicated as being the greatest contributors to the various forms of halitosis)
      2. these VSCs likely the result of intestinal bacterial activity
      3. of all the VSC gasses produced in the colon, >90% are absorbed by the gut lining rather than being emitted as flatus
      4. insufficiency of normal methionine pathway likely result in dimethylsulfidemia in addition to hypermethioninemia
  4. Presentation by Irene Gabashvili, PhD
    Founder of
    Aurametrix
    MEBO Research Scientific Director
    Member of the MEBO Institutional Review Board


    Irene'PowerPoint presentation explains how Aurametrics can serve sufferers of malodor conditions to identify their personal triggers in the diet, medications, hormones, environment, etc., and by doing so, how to best manage symptoms until a cure is discovered. http://www.meboresearch.org/Aurametrix%20presentation%20Miami_meetup_June_2012.pdf
  5. Statistic Report provided by:
    Nigel Manning
    Principal Clinical Scientist
    Department Clinical Chemistry
    Sheffield Children's Hospital
    MEBO Research Scientific Advisor



  6. Letter to the community from
    Adrian John McClay
    UK MEBO Assistant Executive Director
    Member of the Institutional Review Board



    Purpose for Members Center:

    1. Enables better understanding of how many people are potentially affected by malodor.
    2. Enables sufferers to participate in research.
    3. Includes information that has scientific credibility in order for members to be able to trust its validity.
    4. Could potentially demonstrate the size of the malodor community and the spectrum of possible conditions.
    5. To qualify members to participate in research.
    6. To develop a database of symptoms, tests, treatments and benefits of sufferers to identify patterns in the community.

    Functions of the Members Center:
    • Keep members up to date with the most recent information.
    • General advice and information on speaking with medical professionals.
    • Protocol information.
    • Community research.
    http://www.meboresearch.org/Members%20Center%20letter%20from%20AJ.pdf


  7. Letter to the community from
    Karen James
    MEBO UK Public Relations Director


    We should never allow ourselves to be dragged down by the scepticism of fellow sufferers regarding ‘raising awareness’ campaigns; thanks to the UK raising awareness campaigns last year, synchronised e-mailing to the Royal College of General Practitioners (RCGP) and follow-up letters and calls, I managed to publish an ‘odour article’ in ‘Innovait’, which is a journal for graduating doctors published by the RCGP. http://www.meboresearch.org/Karen%27s%20letter%20re%20InnovAiT%20RAISING%20AWARENESS%20CAMPAIGN.pdf


  8. PowerPoint Presentation by
    Glenna Gonzalez, MBA

    MEBO US Public Relations Director
    Life Coach

    Focus on living with body odor and/or breath malodor condition.
    http://www.meboresearch.org/Glennas%20Presentation%20The%20Right%20Perspective%20is%20Everything%21%20MEBO%20Miami%20Beach%20Meetup%202012.ppt

  9. Presentation by
    Cheryl Fields
    MEBO US Community Outreach Director
    Member of the MEBO Institutional Review Board


    Seeking Employment
    1. Stop trying to make "objective statements" happen
    2. Be concrete
    3. Cover letters are back
    4. Keywords are your friend
    5. Get creative with quick response codes
    6. Wow with visual résumés
    7. Give video a chance
    8. Social media are here to stay
    9. http://www.meboresearch.org/Cheryl%27s%20MIA%20BCH%20presentation%20Seeking%20Employment.pdf
It is so moving and awe inspiring to think that every single person involved in the creation of this meetup and the conference projects are volunteers who have given up their precious time for the betterment of all sufferers from around the world. On behalf of all the international community from all corners of the world, I wish to express my most profound appreciation to all the experts who have worked long hours to create these presentations for us. They serve not only to educate sufferers and experts, but to lead us into a new era filled with hope for testing, research, and discoveries that will change our lives and that of our offspring.
halitosis research María de la Torre Founder and Executive Director A Public Charity www.meboresearch.org maria.delatorre@meboresearch.org MEBO's Blog (English) El Blog de MEBO (español)

María

María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

0 comments:

Post a Comment